Eli Lilly & Co. vs. Wave Life Sciences Ltd. Ordinary Shares
Eli Lilly & Co. and Wave Life Sciences Ltd. Ordinary Shares are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| LLY | WVE | |
|---|---|---|
| Market Cap | $1.10 trillion | $994.11 million |
| Revenue (TTM) | — | $65.37 million |
| Net Income (TTM) | — | $-202,473,000 |
LLY leads on 1 of 1 size & scale factors.
Valuation
| LLY | WVE | |
|---|---|---|
| Price / Book | — | 2.19 |
| Price / Sales | — | 15.21 |
LLY and WVE split the valuation factors evenly.
Profitability
| LLY | WVE | |
|---|---|---|
| Net Margin | — | -309.73% |
| Return on Equity | — | -44.64% |
LLY and WVE split the profitability factors evenly.
Risk & Sentiment
| LLY | WVE | |
|---|---|---|
| Short Interest | 1.29% | 1.22% |
WVE leads on 1 of 1 risk & sentiment factors.
Dig deeper: LLY overview, LLY financials, WVE overview, WVE financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.